S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
Fig 5
Linear regression analysis between serum S100A9 level and some clinical parameters, and its diagnostic value in definite NASH.
Correlation between serum S100A9 level and (A) NAS, steatosis, lobular inflammation, (B) ALT, AST, TBil, (C) FBG, HOMA-IR, TG and TC in rats of all groups. (D) The receiver operating characteristic (ROC) curve of S100A9 and CK18 for the definite NASH diagnosis in rats. Area under the ROC (AUROC) for S100A9 and CK18 is 0.947 and 0.931 respectively.